IL6 and lung carcinoma: Although clinical studies attempt with IL-6 or its receptor antibodies have had some success ameliorating lung cancer-related anemia and weight loss, these treatments could not prevent tumor expansion and its effect on muscle mass remains unknown [29,30,31].